Cardiff Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.About CRDF
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
CRDF Key Statistics
Stock Snapshot
The current Cardiff Oncology(CRDF) stock price is $0.86, with a market capitalization of 67.47M. The stock trades at a price-to-earnings (P/E) ratio of -1.43.
On 2026-11-03, Cardiff Oncology(CRDF) stock traded between a low of $0.84 and a high of $0.88. Shares are currently priced at $0.86, which is +2.6% above the low and -2.3% below the high.
Cardiff Oncology(CRDF) shares are trading with a volume of 203.88K, against a daily average of 395.25K.
During the past year, Cardiff Oncology(CRDF) stock moved between $0.76 at its lowest and $3.31 at its peak.
During the past year, Cardiff Oncology(CRDF) stock moved between $0.76 at its lowest and $3.31 at its peak.
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.